Results 181 to 190 of about 1,674,266 (211)

Expression of NK-associated surface-antigens cd-56 and cd-16 on aml-cells.

Oncology Reports, 1994
Monoclonal antibodies Leu 11a (CD16) and Leu 19 (CD56) were tested for reactivity with cells from 36 patients with acute myelogenous leukemia (AML) using two-colour flow cytometry. Blast cells were identified by a broad panel of monoclonal antibodies.
W. Zeller, B. Schafer, A. Benz, K. Gutensohn, K. Becker, W. Fiedler, D. Hossfeld   +6 more
semanticscholar   +4 more sources

Abnormal Expression of CD Antigens in Mastocytosis

International Archives of Allergy and Immunology, 2002
Human mast cells are myeloid cells derived from human pluripotential CD34+ stem cells. Normal mast cells exhibit a myeloid immunophenotype characterized by the expression of CD117, CD33 and FcΕRI in the absence of reactivity for CD14, CD15 and lymphoid-lineage-associated antigens.
L. Escribano, Beatriz Díaz‐Agustín, R. Núñez, A. Prados, R. Rodríguez, A. Órfão   +5 more
semanticscholar   +4 more sources

CD antigens 2002.

Blood, 2002
The process of categorizing the antigenic molecules and epitopes associated with human white cells, via the collaborative study of monoclonal antibodies, dates back to the early 1980s, when the first HLDA (Human Leucocyte Differentiation Antigen) Workshop was held in Paris.
D. Mason, P. André, A. Bensussan, C. Buckley, C. Civin, E. Clark, M. de Haas, S. Goyert, M. Hadam, D. Hart, V. Hořejší, S. Meuer, J. Morrissey, R. Schwartz-Albiez, S. Shaw, D. Simmons, M. Uguccioni, E. van der Schoot, É. Vivier, H. Zola   +19 more
semanticscholar   +3 more sources

Human Leucocyte Differentiation Antigens: Review of the CD Nomenclature

Pathology, 1990
In February 1989 the 4th International Workshop and Conference on Human Leucocyte Differentiation Antigens was held in Vienna. At this meeting the structure and function of recognized cellular antigens was reviewed and new antigens defined. In addition, information was obtained on the molecular genetics of antigens from gene cloning and sequencing. The
W. Erber
semanticscholar   +4 more sources

Human leukocyte differentiation antigens as therapeutic targets: the CD molecules and CD antibodies

Expert Opinion on Biological Therapy, 2001
The cell membrane presents an attractive target in a number of different disease situations. Most obviously, malignant cells may be killed by damaging their cell membranes. There are also more subtle, though effective, ways of rendering cells harmless by engaging proteins at the cell surface.
H. Zola
semanticscholar   +5 more sources

The molecular basis of CD 1 ‐mediated presentation of Iipid antigens

Immunological Reviews, 1999
D. Moody, G. S. Besra, I. Wilson, Steven A. Porceili   +3 more
semanticscholar   +1 more source

Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non‐haemopoietic distribution using panels of monoclonal antibodies belonging to CD‐11b, CD‐13 and CD‐33

British Journal of Haematology, 1988
E. Favaloro, K. F. Bradstock, A. Kabral, P. Grimsley, H. Zowtyj, H. Zola   +5 more
semanticscholar   +1 more source

Update: new CD antigens, 1996

Tissue Antigens, 1997
von dem Borne Ae, Tadamitsu Kishimoto, S Goyert, Ko Okumura, Kazuo Sugamura, Don Mason, Hitoshi Kikutani, Timothy A. Springer, Masayuki Miyasaka, T. Ohno, H. Sugawara, Heddy Zola, L. Moretta, Stephen Shaw   +13 more
openaire   +3 more sources